Duration of beta-blockade with metoprolol and atenolol: influence of drug oxidation.
The beta-blocking activity of two slow-release formulations of metoprolol was compared to conventional metoprolol and atenolol which were each given once daily for one week to 8 healthy volunteers in a balanced crossover study. Plasma levels of metoprolol were also measured. Only metoprolol SA (Astra) produced plasma concentrations significantly higher than those for conventional metoprolol 24 hours after dosing. Mean reduction in exercise tachycardia at 24 hours after dosing was significantly greater with atenolol and metoprolol SA than with metoprolol SR and conventional metoprolol. Beta-adrenoceptor blocking activity at 24 hr was more variable with all formulations of metoprolol than with atenolol, which was explained by differences in metoprolol metabolism. Subjects who were found to be "poor metabolizers" when tested with debrisoquine had much greater bioavailability, half-life and response to metoprolol. These subjects had maintained beta-blocking activity at 24 hr following metoprolol whereas extensive metabolizers did not, even with sustained-release formulations. The response to atenolol did not depend on oxidation phenotype.
D001262:Atenolol / Q000494:pharmacology*; D003692:Delayed-Action Preparations; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008790:Metoprolol / Q000097:blood / Q000494:pharmacology*; D010084:Oxidation-Reduction; D013997:Time Factors
D003692:Delayed-Action Preparations; D001262:Atenolol; D008790:Metoprolol